Post by KeriMedical

A major milestone for Australian patients and hand surgeons. We are proud to announce that the TOUCH® CMC 1 Prosthesis has been granted a listing on Australia's Prescribed List, effective 1 July 2026. For more than a decade, the TOUCH® prosthesis has helped patients across Europe regain thumb function and improve their quality of life. Thanks to this listing, Australian patients will now have access to the same proven technology for the treatment of thumb osteoarthritis (rhizarthrosis). TOUCH® is a dual-mobility trapeziometacarpal prosthesis designed to relieve pain, restore mobility, and preserve the trapezium bone. This achievement marks an important step in expanding access to innovative solutions for patients suffering from thumb osteoarthritis and reinforces our commitment to advancing hand surgery worldwide. #HandSurgery #ThumbOsteoarthritis #Rhizarthrosis #CMC1 #KeriMedical #ThumbArthroplasty